SV2010003725A - Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas - Google Patents
Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativasInfo
- Publication number
- SV2010003725A SV2010003725A SV2010003725A SV2010003725A SV2010003725A SV 2010003725 A SV2010003725 A SV 2010003725A SV 2010003725 A SV2010003725 A SV 2010003725A SV 2010003725 A SV2010003725 A SV 2010003725A SV 2010003725 A SV2010003725 A SV 2010003725A
- Authority
- SV
- El Salvador
- Prior art keywords
- treatment
- espiro
- piperidines
- neurodegenerative diseases
- new class
- Prior art date
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 150000003053 piperidines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5042308P | 2008-05-05 | 2008-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SV2010003725A true SV2010003725A (es) | 2011-07-05 |
Family
ID=40902870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SV2010003725A SV2010003725A (es) | 2008-05-05 | 2010-11-05 | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20110046160A1 (enExample) |
| EP (1) | EP2300484B1 (enExample) |
| JP (1) | JP2011519913A (enExample) |
| KR (1) | KR20110000749A (enExample) |
| CN (1) | CN102083841A (enExample) |
| AP (1) | AP2010005456A0 (enExample) |
| AT (1) | ATE537178T1 (enExample) |
| AU (1) | AU2009245322B2 (enExample) |
| BR (1) | BRPI0912433A2 (enExample) |
| CA (1) | CA2721786A1 (enExample) |
| CO (1) | CO6321280A2 (enExample) |
| CR (1) | CR11759A (enExample) |
| DO (1) | DOP2010000317A (enExample) |
| EA (1) | EA201001566A1 (enExample) |
| EC (1) | ECSP10010597A (enExample) |
| ES (1) | ES2375913T3 (enExample) |
| IL (1) | IL208793A0 (enExample) |
| MA (1) | MA32290B1 (enExample) |
| MX (1) | MX2010012066A (enExample) |
| NZ (1) | NZ588589A (enExample) |
| SV (1) | SV2010003725A (enExample) |
| WO (1) | WO2009136350A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| EP2556076A2 (en) * | 2010-04-09 | 2013-02-13 | Pfizer Inc. | Novel sultam compounds |
| WO2012138734A1 (en) | 2011-04-07 | 2012-10-11 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| EP2694521B1 (en) | 2011-04-07 | 2015-11-25 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| RU2014111055A (ru) | 2011-08-22 | 2015-09-27 | Мерк Шарп И Доум Корп. | 2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение |
| EP3233799B1 (en) | 2014-12-19 | 2021-05-19 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
| EP3233077B1 (en) | 2014-12-19 | 2026-05-06 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2359707T3 (es) * | 2004-01-08 | 2011-05-26 | F. Hoffmann-La Roche Ag | Derivados de diaza-espiropiperidina. |
| JP2006044497A (ja) * | 2004-08-05 | 2006-02-16 | Toyota Motor Corp | 車輪情報処理装置 |
| WO2006044497A2 (en) * | 2004-10-13 | 2006-04-27 | Merck & Co., Inc. | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease |
| CA2615656A1 (en) * | 2005-07-18 | 2007-01-25 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| WO2008030412A2 (en) * | 2006-09-07 | 2008-03-13 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| EP2117309B1 (en) * | 2007-01-04 | 2013-11-06 | Merck Sharp & Dohme Corp. | Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
-
2009
- 2009-05-04 EA EA201001566A patent/EA201001566A1/ru unknown
- 2009-05-04 JP JP2011508035A patent/JP2011519913A/ja not_active Withdrawn
- 2009-05-04 MX MX2010012066A patent/MX2010012066A/es not_active Application Discontinuation
- 2009-05-04 WO PCT/IB2009/051815 patent/WO2009136350A1/en not_active Ceased
- 2009-05-04 CA CA2721786A patent/CA2721786A1/en not_active Abandoned
- 2009-05-04 US US12/990,739 patent/US20110046160A1/en not_active Abandoned
- 2009-05-04 EP EP09742523A patent/EP2300484B1/en active Active
- 2009-05-04 KR KR1020107024794A patent/KR20110000749A/ko not_active Ceased
- 2009-05-04 NZ NZ588589A patent/NZ588589A/en not_active IP Right Cessation
- 2009-05-04 CN CN2009801261947A patent/CN102083841A/zh active Pending
- 2009-05-04 AP AP2010005456A patent/AP2010005456A0/xx unknown
- 2009-05-04 BR BRPI0912433A patent/BRPI0912433A2/pt not_active Application Discontinuation
- 2009-05-04 ES ES09742523T patent/ES2375913T3/es active Active
- 2009-05-04 AT AT09742523T patent/ATE537178T1/de active
- 2009-05-04 AU AU2009245322A patent/AU2009245322B2/en not_active Ceased
-
2010
- 2010-10-18 IL IL208793A patent/IL208793A0/en unknown
- 2010-10-21 DO DO2010000317A patent/DOP2010000317A/es unknown
- 2010-10-26 CR CR11759A patent/CR11759A/es not_active Application Discontinuation
- 2010-11-05 SV SV2010003725A patent/SV2010003725A/es not_active Application Discontinuation
- 2010-11-05 MA MA33328A patent/MA32290B1/fr unknown
- 2010-11-09 EC EC2010010597A patent/ECSP10010597A/es unknown
- 2010-11-11 CO CO10141834A patent/CO6321280A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CO6321280A2 (es) | 2011-09-20 |
| ECSP10010597A (es) | 2010-12-30 |
| CA2721786A1 (en) | 2009-11-12 |
| IL208793A0 (en) | 2010-12-30 |
| MX2010012066A (es) | 2010-12-06 |
| CR11759A (es) | 2010-11-22 |
| AU2009245322B2 (en) | 2011-07-14 |
| AP2010005456A0 (en) | 2010-12-31 |
| CN102083841A (zh) | 2011-06-01 |
| NZ588589A (en) | 2012-07-27 |
| MA32290B1 (fr) | 2011-05-02 |
| AU2009245322A1 (en) | 2009-11-12 |
| KR20110000749A (ko) | 2011-01-05 |
| DOP2010000317A (es) | 2010-11-15 |
| BRPI0912433A2 (pt) | 2015-12-22 |
| EA201001566A1 (ru) | 2011-04-29 |
| WO2009136350A1 (en) | 2009-11-12 |
| US20110046160A1 (en) | 2011-02-24 |
| EP2300484B1 (en) | 2011-12-14 |
| JP2011519913A (ja) | 2011-07-14 |
| EP2300484A1 (en) | 2011-03-30 |
| ES2375913T3 (es) | 2012-03-07 |
| ATE537178T1 (de) | 2011-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8785801A1 (es) | Compuestos heterocìclicos | |
| UY30500A1 (es) | Compuestos de azabencimidazolilo | |
| UY32977A (es) | Novedosos compuestos como inhibidores de la caseina quinasa | |
| SV2011003916A (es) | Nuevas lactamas como inhibidores de beta secretasa | |
| UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| CU20110233A7 (es) | Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas | |
| CR20140399A (es) | Pirrolidina-2-carboxamidas sustituidas | |
| PA8779901A1 (es) | Compuestos amino-heterocíclicos | |
| CU20110207A7 (es) | Aril piridinas como inhibidoras de sintasa de aldosterona | |
| UY32574A (es) | Antagonistas del receptor cxcr3 | |
| CY1118662T1 (el) | Νεες δικυκλικες πυριδινονες | |
| UY33536A (es) | INHIBIDORES BICÍCLICOS DE ACETIL-CoA-CARBOXILASA Y USOS DE LOS MISMOS | |
| CU24087B1 (es) | Compuestos de carbazol | |
| CO6480932A2 (es) | Antagonistas de la trayectoria hedgehog de ftalazina disustituida. | |
| CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
| UY31870A (es) | Receptor metabotrópico de glutamato potenciadores 286 | |
| CY1118093T1 (el) | Φαρμακοτεχνικες μορφες που περιλαμβανουν παραγωγα 1-(bhta-d-γλυκοπυρανοζυλ)-2-θειενυλμεθυλβενζολιου ως αναστολεις sglt | |
| MX2012004311A (es) | Derivados de ciclohexano spiro condensados como inhibidores de lipasa sensible a hormonas (hsl) utiles en el tratamiento de diabetes. | |
| DOP2010000317A (es) | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
| EA201290229A1 (ru) | Производные спиролактама и их применение | |
| ECSP13012838A (es) | Nuevos compuestos de benzodioxol-piperazina | |
| ATE495159T1 (de) | Diaminocyclohexan- und diaminocyclopentanderivate | |
| GEP20156269B (en) | New secondary 8-hydroxyquinoline-7- carboxamide derivatives | |
| CU20100210A7 (es) | Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas | |
| UY33857A (es) | Compuestos de tiofeno 2,3,5-trisustituidos y usos de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Lapse |